NEUROLOGY
June 16, 2023
Alzheimer’s Disease and Current Treatment
Two approved monoclonal antibodies have demonstrated that removing beta-amyloids from the brain reduces cognitive and functional decline in early stages.June 16, 2023
Tardive Dyskinesia
May 19, 2023
Adderall 1 mg/mL Oral Suspension
May 19, 2023
Drug Therapy for Obsessive-Compulsive Disorder
March 17, 2023
Current Monoclonal Antibody Options for Multiple Sclerosis
March 17, 2023
Pain-Management Approaches for Peripheral Neuropathy
February 17, 2023
Stroke Rates and Hospitalizations
January 26, 2023
Assisted Reproduction Technology and Risk of Developing MS
January 26, 2023
Study Reveals Gender Differences in Cluster Headaches
January 19, 2023
Lamotrigine 1 mg/mL Compounded Oral Suspension, USP
January 19, 2023
Community Pharmacists’ Role in the Treatment of Epilepsy
January 19, 2023
Risks and Considerations for Epilepsy
January 19, 2023
Managing Glaucoma
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2023 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.